The Chimeric Adenovirus (Ad5/35) Expressing Engineered Spike Protein Confers Immunity against SARS-CoV-2 in Mice and Non-Human Primates.
Shin SP, Shin KS, Lee JM, Jung IK, Koo J, Lee SW, Park S, Shin J, Park M, Park B, Oh H, Koo BS, Hong J, Ryu CM, Kim JO, Oh T, Kang CY.
Shin SP, et al.
Vaccines (Basel). 2022 Apr 30;10(5):712. doi: 10.3390/vaccines10050712.
Vaccines (Basel). 2022.
PMID: 35632468
Free PMC article.